Breast Cancer Trial, Recruiting NCT06773897 Sponsor: Rutgers, The State University of New Jersey Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06773897
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are currently living in the United States
  • People who are able to read and follow written instructions in English
  • People who have access to the internet and a device such as a computer, laptop, tablet, or smartphone
  • People who are willing to give written consent to take part in the study
  • People who are willing to provide a saliva sample for DNA collection using a kit that would be mailed to their home
  • People who are willing to fill out a health survey with questions related to breast cancer research

Who may not be able to join:

  • People who are unable to meet all of the criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tara Matise, Ph.D., Rutgers, The State University of New Jersey

Phone: 848-445-3125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rutgers, The State University of New Jersey
Registry
ClinicalTrials.gov
Start date
15 April 2024
Est. completion
15 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Genetic risk variants associated with breast cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov